KabbinavarF.F.HambletonJ.MassR.D.Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer.J Clin Oncol2005; 23: 3706–12.
2.
KozloffM.YoodM.U.BerlinJ.Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.Oncologist2009; 14: 862–70.
3.
SugrueM.KozloffM.HainsworthJ.Risk factors for gastrointestinal patients with metastatic colorectal cancer receiving bevacizumab plus chemotherapy.J Clin Oncol2006; 24(suppl): 3535.
4.
BegeT.LelongB.ViretF.Bevacizumab-related surgical site complications despite primary tumor resection in colorectal cancer patients.Ann Surg Oncol2009; 16: 856–60.